Navigation Links
Lorus Therapeutics Receives $600 Thousand From Escrow Account
Date:7/16/2008

TORONTO, July 16 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" or the "Corporation"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, today announced that the Corporation has received the $600 thousand originally held in escrow in connection with Lorus' corporate reorganization completed on July 10, 2007. The Corporation has received total net proceeds of $6.9 million in non-dilutive financing as part of this transaction.

For further information about the corporate reorganization, please refer to our press release dated July 10, 2007 available on Lorus' website or at Sedar.com.

Forward Looking Statements

This press release may contain forward-looking statements within the meaning of Canadian and U.S. securities laws. Such statements include, but are not limited to, statements relating to: our research program plans, our plans to conduct clinical trials, the successful and timely completion of clinical studies and the regulatory approval process, our ability to fund future research, our plans to obtain partners to assist in the further development of our product candidates, the establishment of corporate alliances, the Company's plans, objectives, expectations and intentions and other statements including words such as "continue", "believe", "plan", "expect", "intend", "will", "should", "may", and other similar expressions. Such statements reflect our current views with respect to future events and are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by us are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance, or achi
'/>"/>

SOURCE Lorus Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
2. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
3. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
4. Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040
5. Lorus initiates development program exploring novel route of administration for LOR-2040
6. Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
7. Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
8. Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
11. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... PHILADELPHIA, Dec. 15 The Center ... Advanstar Communications, is pleased to announce the ... Pharmaceutical/Biotech Accounting and Reporting Congress . The ... Philadelphia, on March 16-17, 2010. ,, Over ... professionals have attended this premier event since ...
(Date:12/15/2009)... 15 Thomson ... has become the first drug pipeline database to ... information. This highly anticipated new content is being ... ,, Thomson Pharma will ... publications, press releases, conferences, and other sources across ...
(Date:12/15/2009)... Prinz Law Office has announced the launch of several ... secure legal services in the current economic climate. ... the opportunity to finance legal services over a period ... any equity in their start-up companies. The second ... fixed montly payment arrangements over 6 to 12 month ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
Breaking Biology Technology:CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4
... , Mark Churchill 1 , Mark Harrison 1 , , ... 1 Thermo Finnigan, Stafford House, 1 Boundary Park, Boundary Way, Hemel , ... Hormone Laboratory, Section for Doping Analysis,Trondheimsveien, , N-0514, Oslo, Norway, , ... Monitoring Clenbuterol in Humans , , , , ...
... , , , , , ... offering complete walkaway automation for the isolation and purification , ... of Companies and is now , known as QIAGEN ... of DNA and , RNA from a variety ...
... optimal reagent for your cells , , , , , , , ... Storage and Stability , Quality Control , Technical Assistance ... , SuperFect Transfection Reagent , ... Effectene Transfection Reagent , , , ...
Other Biology Technology:Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 2Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 3Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 4Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 5Walkaway automation for nucleic acid purification 2Transfection Reagent Selector Kit Handbook 2Transfection Reagent Selector Kit Handbook 3Transfection Reagent Selector Kit Handbook 4Transfection Reagent Selector Kit Handbook 5Transfection Reagent Selector Kit Handbook 6Transfection Reagent Selector Kit Handbook 7Transfection Reagent Selector Kit Handbook 8Transfection Reagent Selector Kit Handbook 9Transfection Reagent Selector Kit Handbook 10Transfection Reagent Selector Kit Handbook 11Transfection Reagent Selector Kit Handbook 12Transfection Reagent Selector Kit Handbook 13Transfection Reagent Selector Kit Handbook 14Transfection Reagent Selector Kit Handbook 15Transfection Reagent Selector Kit Handbook 16Transfection Reagent Selector Kit Handbook 17Transfection Reagent Selector Kit Handbook 18Transfection Reagent Selector Kit Handbook 19Transfection Reagent Selector Kit Handbook 20Transfection Reagent Selector Kit Handbook 21Transfection Reagent Selector Kit Handbook 22Transfection Reagent Selector Kit Handbook 23Transfection Reagent Selector Kit Handbook 24Transfection Reagent Selector Kit Handbook 25Transfection Reagent Selector Kit Handbook 26Transfection Reagent Selector Kit Handbook 27Transfection Reagent Selector Kit Handbook 28Transfection Reagent Selector Kit Handbook 29Transfection Reagent Selector Kit Handbook 30
(Date:12/11/2009)... species of wild apples that could be an ancestor ... and Central Asia. A new study comparing the diversity ... Georgia and Armenia with previously collected varieties originating in ... a core collection that will make M. orientalis ... , To identify and record the genetic diversity of ...
(Date:12/11/2009)... does a cell manage to identify and degrade the ... body against serious diseases? The researchers Sabine C. Horn, ... Jarosch of the Max Delbrck Center for Molecular Medicine ... in this puzzle. In an enzyme complex that plays ... they discovered a scaffold regulating the identification and disposal ...
(Date:12/11/2009)... in French . , Montreal, December ... molecular mechanism that prevents cancer. In the December 11 ... scientists from the Universit de Montral and the Universit ... molecule prevents the cancer-causing activity of cytokines, hormones that ... Crohns, in smokers and people exposed to asbestos. ...
Breaking Biology News(10 mins):Understanding apples' ancestors 2MDC researchers identify a scaffold regulating protein disposal 2Scientists identify natural anti-cancer defenses 2Susies Big Adventure Explores Plastic Surgery In Saudi Arabia 53959 1Steroid Can Ease Severe Sore Throat 53956 1Steroid Can Ease Severe Sore Throat 53956 2Steroid Can Ease Severe Sore Throat 53956 3Insulet Corporation to Present at Upcoming Investor Conferences 53953 1Insulet Corporation to Present at Upcoming Investor Conferences 53953 2
... students may handle stressful situations better if they have a pet. ... of life for people who are aging or those who are ... many college students may also benefit from owning a cat or ... university and other adults in the area found that nearly a ...
... CAMBRIDGE, Mass., Dec. 23, 2008 -- The reproductive spores ... shapes, according to new research by mycologists and applied ... scientists report this week in the Proceedings of ... by these fungal spores is within one percent of ...
... In a study that challenges current ideas about the insect ... to exaggerate. , Normally, foraging honey bees alert their comrades ... nectar or pollen, and only when the hive is in ... "round" or "waggle" dance, on a specialized "dance floor" in ...
Other Biology News:College students find comfort in their pets during hard times 2College students find comfort in their pets during hard times 3In many fungi, reproductive spores are remarkably aerodynamic 2Honey bees on cocaine dance more, changing ideas about the insect brain 2Honey bees on cocaine dance more, changing ideas about the insect brain 3
... system, 100-120 V, is used for protein ... (IEF). The system includes both the mini ... chambers, chassis, harvesting apparatus, cooling finger, electrode ... 60 ml syringe, colored protein sample, 2 ...
...
... SIGNETs BCIP/NBT Chromogen system ... Tetrazolium] chromogen in a single ... reacts in the presence of ... staining with minimal background noise. ...
... Chromogen system consists of [5-Bromo-4-Chloro-3-,Indolyl ... a single component,solution. The ready-to-use ... presence of alkaline phosphatase to ... minimal background noise. ,The System ...
Biology Products: